1.
Akumu EO. Balancing Favourable Drug-Likeness Against Respiratory and Renal Liabilities: An Integrated In Silico ADME–Toxicity Profile of a Novel 3-{[2-(Formimidoylamino)ethyl]sulfanyl}-6-(1-methoxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carbonyl fluoride. Editon Cons. j. res. med. health sci. [Internet]. 2026 Sep. 12 [cited 2026 Sep. 20];6(1):28-40. Available from: https://editoncpublishing.org/ecpj/index.php/ecjrmhs/article/view/758